Then, based on the PPI and MCODE analysis, the three hub genes, SNRPD2, SNRPD3, and EIF4A3, had been screened out and been identified as the useful biomarkers to predict the metastasis in the MM patients by ROC curve and expression value analysis in the GSE8401. This evidence concerns the gene SNRPD3 and Miyoshi myopathy.